Could the mosaic pattern of chromosomal abnormality predict overall survival of patients with myelodysplastic syndrome?
Hematology, Oncology and Stem Cell Therapy. 2016; 9 (2): 41-47
Dans Anglais
| IMEMR
| ID: emr-182864
ABSTRACT
Objective/background:
Myelodysplastic syndromes [MDSs] are a group of monoclonal hematopoietic diseases consisting of a number of various entities. The presence of differences in chromosomal content of cells within the same individual is known as chromosomal mosaicism. The impact of mosaic pattern on the prognosis of MDS has been unclear. In this study, we aimed to determine the impact of mosaic pattern on the survival of patients with MDS
Recherche sur Google
Indice:
Méditerranée orientale
langue:
Anglais
Texte intégral:
Hematol. Oncol. Stem Cell Ther.
Année:
2016
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS